Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Other financing activities (2024)

Lexicon Pharmaceuticals (LXRX) has disclosed Other financing activities for 2 consecutive years, with -$1000.0 as the latest value for Q4 2024.

  • Quarterly Other financing activities changed N/A to -$1000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$1000.0 through Sep 2025, up 99.92% year-over-year, with the annual reading at -$1.3 million for FY2024, N/A changed from the prior year.
  • Other financing activities for Q4 2024 was -$1000.0 at Lexicon Pharmaceuticals, up from -$906000.0 in the prior quarter.
  • The five-year high for Other financing activities was -$1000.0 in Q4 2024, with the low at -$906000.0 in Q3 2024.